Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ALK |
| Variant | F1174V |
| Impact List | missense |
| Protein Effect | gain of function - predicted |
| Gene Variant Descriptions | ALK F1174V lies within the protein kinase domain of the Alk protein (UniProt.org). F1174V results in constitutive activation of the Alk protein in cell culture (PMID: 21242967) and has been demonstrated to occur as a secondary resistance mutation in the context of ALK fusions (PMID: 24675041), and therefore, is predicted to lead to a gain of Alk protein function. |
| Associated Drug Resistance | Y |
| Category Variants Paths |
ALK mutant ALK act mut ALK F1174V ALK mutant ALK F1174X ALK F1174V |
| Transcript | NM_004304.5 |
| gDNA | chr2:g.29220831A>C |
| cDNA | c.3520T>G |
| Protein | p.F1174V |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004304 | chr2:g.29220831A>C | c.3520T>G | p.F1174V | RefSeq | GRCh38/hg38 |
| NM_004304.4 | chr2:g.29220831A>C | c.3520T>G | p.F1174V | RefSeq | GRCh38/hg38 |
| NM_004304.5 | chr2:g.29220831A>C | c.3520T>G | p.F1174V | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|